• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提取物的治疗潜力:调节链脲佐菌素诱导的大鼠模型中的 IL-35、TNF-α 和血液学特征。

Therapeutic potential of extract: Modulating IL-35, TNF-α, and hematology profile in streptozotocin-induced rat model.

机构信息

Department of Pathology, Faculty of Veterinary Medicine, University of Wijaya Kusuma Surabaya, Surabaya, Indonesia.

Department of Basic Veterinary Medicine, Faculty of Veterinary, Universitas Airlangga, Kampus C UNAIR, Surabaya, Indonesia.

出版信息

Open Vet J. 2024 Sep;14(9):2250-2255. doi: 10.5455/OVJ.2024.v14.i9.12. Epub 2024 Sep 30.

DOI:10.5455/OVJ.2024.v14.i9.12
PMID:39553780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11563615/
Abstract

BACKGROUND

Diabetes mellitus is a significant global health issue with increasing prevalence

AIM

This study aims to investigate the potential of extract (TE) in lowering interleukin-35 (IL-35), tumor necrosis factor-alpha (TNF-α), and hematological profile in streptozotocin (STZ)-induced rats.

METHODS

A total of 24 rats were divided into four treatment groups: control (P0), diabetic induction (P1), diabetic induction + TE (P2), and diabetic induction + quercetin (P3). Diabetes mellitus was induced by a single-dose injection of stz (60 mg/kg). TE treatment was administered orally for 7 days. On the 8th day post-treatment, all animals were euthanized, and blood samples were collected to assess inflammatory parameters, including IL-35, TNF-α, GPx, and hematological profiles. Kidney organs were fixed in 10% buffered neutral formalin for histopathological analysis. Data were analyzed using ANOVA followed by Duncan's test ( < 0.05).

RESULTS

Evaluation of the hematological profile revealed significant improvements in the P2 and P3 groups, with decreased leukocytes, hemoglobin, lymphocytes, and neutrophils, as well as significantly lower IL-35 and TNF-α levels observed in diabetic rats following TE treatment.

CONCLUSION

TE treatment exhibited promising effects in reducing inflammatory markers and restoring hematological parameters in diabetic rats, indicating its potential as a therapeutic agent in diabetic rats.

摘要

背景

糖尿病是一个全球性的重大健康问题,其患病率正在不断上升。

目的

本研究旨在探讨 提取物(TE)降低链脲佐菌素(STZ)诱导的大鼠白细胞介素 35(IL-35)、肿瘤坏死因子-α(TNF-α)和血液学特征的潜力。

方法

将 24 只大鼠分为四组:对照组(P0)、糖尿病诱导组(P1)、糖尿病诱导+TE 组(P2)和糖尿病诱导+槲皮素组(P3)。通过单次注射 STZ(60mg/kg)诱导糖尿病。TE 治疗通过口服给药进行 7 天。在治疗后第 8 天,所有动物被安乐死,采集血液样本以评估炎症参数,包括 IL-35、TNF-α、GPx 和血液学特征。肾脏器官用 10%缓冲中性福尔马林固定进行组织病理学分析。使用方差分析(ANOVA)和 Duncan 检验(<0.05)进行数据分析。

结果

血液学特征评估显示,P2 和 P3 组有显著改善,白细胞、血红蛋白、淋巴细胞和中性粒细胞减少,糖尿病大鼠经 TE 治疗后 IL-35 和 TNF-α 水平显著降低。

结论

TE 治疗在降低糖尿病大鼠的炎症标志物和恢复血液学参数方面表现出有希望的效果,表明其可能成为糖尿病大鼠的治疗剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dc/11563615/59570adacf09/OpenVetJ-14-2250-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dc/11563615/59570adacf09/OpenVetJ-14-2250-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4dc/11563615/59570adacf09/OpenVetJ-14-2250-g001.jpg

相似文献

1
Therapeutic potential of extract: Modulating IL-35, TNF-α, and hematology profile in streptozotocin-induced rat model.提取物的治疗潜力:调节链脲佐菌素诱导的大鼠模型中的 IL-35、TNF-α 和血液学特征。
Open Vet J. 2024 Sep;14(9):2250-2255. doi: 10.5455/OVJ.2024.v14.i9.12. Epub 2024 Sep 30.
2
Effects of garlic extract on TNF-α expression and oxidative stress status in the kidneys of rats with STZ + nicotinamide-induced diabetes.大蒜提取物对链脲佐菌素+烟酰胺诱导的糖尿病大鼠肾脏中肿瘤坏死因子-α表达及氧化应激状态的影响。
Pharm Biol. 2017 Dec;55(1):526-531. doi: 10.1080/13880209.2016.1255978.
3
The Anti-Diabetic Effect of Some Plant Extracts Against Streptozotocin - Induced Diabetes Type 2 in Male Albino Rats.某些植物提取物对链脲佐菌素诱导的雄性白化病大鼠 2 型糖尿病的降血糖作用。
Endocr Metab Immune Disord Drug Targets. 2021;21(8):1431-1440. doi: 10.2174/1871530320666201016145502.
4
Toxicological Assessment and Anti-diabetic Effects of Combined Extract of Chirata, Fenugreek and Sesame on Regulating TNF-α, TGF-β and Oxidative Stress in Streptozotocin Induced Diabetic Rats.梓醇、胡芦巴和芝麻联合提取物对链脲佐菌素诱导糖尿病大鼠 TNF-α、TGF-β 和氧化应激的毒理学评价及抗糖尿病作用。
Curr Drug Discov Technol. 2024;21(1):e201023222477. doi: 10.2174/0115701638252203230919092315.
5
Comparative effects of metformin and Cistus laurifolius L. extract in streptozotocin-induced diabetic rat model: oxidative, inflammatory, apoptotic, and histopathological analyzes.二甲双胍和劳瑞白千层提取物在链脲佐菌素诱导的糖尿病大鼠模型中的比较作用:氧化应激、炎症、细胞凋亡和组织病理学分析。
Environ Sci Pollut Res Int. 2021 Nov;28(41):57888-57901. doi: 10.1007/s11356-021-14780-y. Epub 2021 Jun 7.
6
Effect of Leaf-extract on Hematological Indices and Lipid Profile of Streptozotocin-induced Diabetic Wistar Rats.叶提取物对链脲佐菌素诱导的糖尿病 Wistar 大鼠血液学指标和脂质谱的影响。
Pak J Biol Sci. 2020 Jan;23(12):1523-1529. doi: 10.3923/pjbs.2020.1523.1529.
7
Protective and antidiabetic effects of extract from Nigella sativa on blood glucose concentrations against streptozotocin (STZ)-induced diabetic in rats: an experimental study with histopathological evaluation.黑种草提取物对链脲佐菌素(STZ)诱导的糖尿病大鼠血糖浓度的保护和降血糖作用:具有组织病理学评价的实验研究。
Diagn Pathol. 2013 Aug 15;8:137. doi: 10.1186/1746-1596-8-137.
8
Assessment of the Anti-Hyperglycaemic, Anti-Inflammatory and Antioxidant Activities of the Methanol Extract of Moringa Oleifera in Diabetes-Induced Nephrotoxic Male Wistar Rats.辣木甲醇提取物对糖尿病诱导的肾毒性雄性Wistar大鼠的降血糖、抗炎和抗氧化活性评估
Molecules. 2017 Mar 23;22(4):439. doi: 10.3390/molecules22040439.
9
Mechanism of antidiabetic effects of Plicosepalus Acaciae flower in streptozotocin-induced type 2 diabetic rats, as complementary and alternative therapy.相思树花在链脲佐菌素诱导的 2 型糖尿病大鼠中的抗糖尿病作用机制,作为补充和替代疗法。
BMC Complement Med Ther. 2020 Sep 23;20(1):290. doi: 10.1186/s12906-020-03087-z.
10
Effect of Curcumin on Characterization and Localization of Interleukin-13 and Tumor Necrosis Factor-alpha in Liver of Diabetic Rats.姜黄素对糖尿病大鼠肝脏中白细胞介素-13和肿瘤坏死因子-α特性及定位的影响
J Med Assoc Thai. 2016 Nov;99 Suppl 8:S187-S195.

本文引用的文献

1
Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways.糖尿病的心血管并发症:从微血管到宏血管途径
Cureus. 2023 Sep 24;15(9):e45835. doi: 10.7759/cureus.45835. eCollection 2023 Sep.
2
Pathophysiology of Red Blood Cell Dysfunction in Diabetes and Its Complications.糖尿病及其并发症中红细胞功能障碍的病理生理学
Pathophysiology. 2023 Aug 2;30(3):327-345. doi: 10.3390/pathophysiology30030026.
3
Analysis of Modifiable, Non-Modifiable, and Physiological Risk Factors of Non-Communicable Diseases in Indonesia: Evidence from the 2018 Indonesian Basic Health Research.
印度尼西亚非传染性疾病的可改变、不可改变和生理风险因素分析:来自2018年印度尼西亚基本卫生研究的证据。
J Multidiscip Healthc. 2022 Sep 30;15:2203-2221. doi: 10.2147/JMDH.S382191. eCollection 2022.
4
Alkaloidal Phytoconstituents for Diabetes Management: Exploring the Unrevealed Potential.生物碱类植物化合物在糖尿病管理中的应用:探索未被揭示的潜力。
Molecules. 2022 Sep 9;27(18):5851. doi: 10.3390/molecules27185851.
5
Effect of Leaf Extract on Leptin, Adiponectin, and Insulin Receptor Levels in Diabetic Rats.叶提取物对糖尿病大鼠瘦素、脂联素和胰岛素受体水平的影响。
Prev Nutr Food Sci. 2022 Mar 31;27(1):63-69. doi: 10.3746/pnf.2022.27.1.63.
6
Streptozotocin-Induced Diabetic Models in Mice and Rats.链脲佐菌素诱导的小鼠和大鼠糖尿病模型。
Curr Protoc. 2021 Apr;1(4):e78. doi: 10.1002/cpz1.78.
7
The Relationship between Erythrocytes and Diabetes Mellitus.红细胞与糖尿病之间的关系。
J Diabetes Res. 2021 Feb 25;2021:6656062. doi: 10.1155/2021/6656062. eCollection 2021.
8
Monocytes and Macrophages as Protagonists in Vascular Complications of Diabetes.单核细胞和巨噬细胞在糖尿病血管并发症中起主要作用。
Front Cardiovasc Med. 2020 Feb 14;7:10. doi: 10.3389/fcvm.2020.00010. eCollection 2020.
9
Abridged for Primary Care Providers.为初级保健提供者缩写。
Clin Diabetes. 2020 Jan;38(1):10-38. doi: 10.2337/cd20-as01.
10
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition.2019 年全球及各区域糖尿病患病率估算值及 2030 年和 2045 年预测值:国际糖尿病联盟糖尿病地图集(第 9 版)的结果。
Diabetes Res Clin Pract. 2019 Nov;157:107843. doi: 10.1016/j.diabres.2019.107843. Epub 2019 Sep 10.